Małolepsza E - Search Results

1

[Transmission of HIV-1 drug resistance among newly diagnosed patients in Poland].

Stańczak GP, Stańczak JJ, Firlag-Burkacka E, Wiercińska-Drapało A, Leszczyszyn-Pynkad M, Jabłonowska E, Małolepsza E, Horban A. Stańczak GP, et al. Among authors: malolepsza e. Przegl Epidemiol. 2007;61(1):29-34. Przegl Epidemiol. 2007. PMID: 17702436 Polish.

2

[Incidence of various types of viral hepatitis in Poland 1988].

Kalinowska B, Małolepsza E, Magdzik W, Naruszewicz-Lesiuk D, Nowosławski A. Kalinowska B, et al. Among authors: malolepsza e. Przegl Epidemiol. 1990;44(4):273-8. Przegl Epidemiol. 1990. PMID: 1966117 Polish.

3

Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.

Podlasin RB, Wiercinska-Drapalo A, Olczak A, Beniowski M, Smiatacz T, Malolepsza E, Juszczyk J, Leszczyszyn-Pynka M, Mach T, Mian M, Knysz B, Horban A. Podlasin RB, et al. Among authors: malolepsza e. Infection. 2006 Aug;34(4):196-200. doi: 10.1007/s15010-006-5030-y. Infection. 2006. PMID: 16896577

4

[Efficacy of vaccination against hepatitis A in HIV infected adults from Lodz region--preliminary report].

Jabłonowska E, Kuydowicz J, Małolepsza E. Jabłonowska E, et al. Among authors: malolepsza e. Przegl Epidemiol. 2008;62(3):605-12. Przegl Epidemiol. 2008. PMID: 19108525 Polish.

5

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.

Kesselring AM, Wit FW, Sabin CA, Lundgren JD, Gill MJ, Gatell JM, Rauch A, Montaner JS, de Wolf F, Reiss P, Mocroft A; Nevirapine Toxicity Multicohort Collaboration. Kesselring AM, et al. AIDS. 2009 Aug 24;23(13):1689-99. doi: 10.1097/QAD.0b013e32832d3b54. AIDS. 2009. PMID: 19487907

6

High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.

Worm SW, Friis-Møller N, Bruyand M, D'Arminio Monforte A, Rickenbach M, Reiss P, El-Sadr W, Phillips A, Lundgren J, Sabin C; D:A:D study group. Worm SW, et al. AIDS. 2010 Jan 28;24(3):427-35. doi: 10.1097/QAD.0b013e328334344e. AIDS. 2010. PMID: 19910787

7

Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe.

Soriano V, Mocroft A, Peters L, Rockstroh J, Antunes F, Kirkby N, de Wit S, Monforte Ad, Flisiak R, Lundgren J; EuroSIDA. Soriano V, et al. J Antimicrob Chemother. 2010 Mar;65(3):548-55. doi: 10.1093/jac/dkp479. Epub 2010 Jan 5. J Antimicrob Chemother. 2010. PMID: 20051475

8

History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.

Reekie J, Mocroft A, Ledergerber B, Beniowski M, Clotet B, van Lunzen J, Chiesi A, Pradier C, Machala L, Lundgren JD; EuroSIDA Study Group. Reekie J, et al. HIV Med. 2010 Aug;11(7):469-78. doi: 10.1111/j.1468-1293.2009.00816.x. Epub 2010 Feb 22. HIV Med. 2010. PMID: 20201975 Free article.

9

Evolving patterns of HIV-1 transmitted drug resistance in Poland in the years 2000-2008.

Stańczak GP, Stańczak JJ, Marczyńska M, Firlag-Burkacka E, Wiercińska-Drapało A, Leszczyszyn-Pynka M, Jabłonowska E, Małolepsza E, Dyda T, Zabek P, Horban A. Stańczak GP, et al. Among authors: malolepsza e. J Med Virol. 2010 Jul;82(7):1291-4. doi: 10.1002/jmv.21782. J Med Virol. 2010. PMID: 20513098

10

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.

Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD; EuroSIDA Study Group. Mocroft A, et al. AIDS. 2010 Jul 17;24(11):1667-78. doi: 10.1097/QAD.0b013e328339fe53. AIDS. 2010. PMID: 20523203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters